Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019, to consider un-audited results for the quarter ended June 30, 2019; and interim dividend for the FY2019-20.
The above information is a part of company’s filings submitted to BSE.